Cancer immunotherapy: exploiting neoepitopes
The efficacy of cancer vaccines has long been hampered by insufficient definition of tumor-specific antigens.A recent study by Kreiter et al.published in Nature has provided a blueprint for a patient-tailored approach to develop individualized RNA vaccines.
25
2015-09-24(万方平台首次上网日期,不代表论文的发表时间)
887-888